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Kidney tubular epithelium is restored without replacement
with bone marrow–derived cells during repair after ischemic
injury. The kidney has the ability to restore the structural
and functional integrity of the proximal tubule, which un-
dergoes extensive epithelial cell death after prolonged ex-
posure to ischemia. In order to study the role that adult
bone marrow–derived stem cells might play in kidney re-
modeling after injury, we employed a murine model of is-
chemia/reperfusion (I/R) injury in which the degree of injury,
dysfunction, repair, tubular cell proliferation and functional re-
covery have been characterized [Park KM, et al, J Biol Chem
276:11870–11876, 2001]. We generated chimeric mice using mar-
row from mice expressing the bacterial LacZ gene, or the
enhanced green fluorescence protein (eGFP) gene, or from
male mice transplanted into female mice. The establishment
of chimerism was confirmed at 6 weeks following transplan-
tation in each case. I/R injury was induced in chimeric mice
by occluding the renal arteries and veins with microaneurysm
clamps for 30 minutes. After functional recovery in the eGFP
chimeras, although there were many interstitial cells, no tubu-
lar cells were derived from bone marrow cells. In the bacterial
b-galactosidase (b-gal) chimeric mice we found evidence of
mammalian (endogenous) b-gal by 5-bomo-4-chloro-3-indolyl-
b-D-galactopyranoside (X-gal) staining, but not bacterial b-gal
in tubule cells. Detection of the Y chromosome by fluores-
cence in situ hybridization (FISH) in the postischemic kidneys
of gender-mismatched chimeras revealed Y chromosome pos-
itivity only in the nuclei of interstitial cells, when scrutinized
by deconvolution microscopy. In our model of I/R injury there
was a large amount of proliferation of surviving, injured tubular
cells indicating that the injured tubule is repopulated by daugh-
ter cells of surviving tubular cells. Analysis of the phenotype
of interstitial and vascular cells following I/R injury revealed
small numbers of peritubular endothelial cells to be derived
from bone marrow cells that may serve in the repair process.
The concept that adult stem cells play a role in re-
nal tubule regeneration has generated considerable inter-
est. Recent reports in the kidney and other organs have
suggested that bone marrow stem cells (BMSCs) have
greater plasticity than originally thought and are able to
differentiate into cells of solid organs [1–8]. The process of
differentiation into parenchymal cells has been reported
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to be augmented following tissue injury, and some au-
thors have concluded that adult stem cells may make an
important contribution to normal tissue repair. We in-
vestigated the contribution of BMSCs comprising both
hematopoietic stem cells (HSCs) and mesenchymal stro-
mal cells (MSCs) to the process of repair in the kidney.
PROLIFERATION OF TUBULE CELLS
FOLLOWING INJURY
The kidney has a remarkable capacity for regener-
ation, as evidenced by complete recovery of function
following acute renal failure. We have previously re-
ported that following ischemia reperfusion injury, ep-
ithelial cells acquire mesenchymal characteristics and as
such represent a form of epithelial-to-mesenchymal ded-
ifferentiation, possibly reflecting a reversal of the process
of mesenchymal-to-epithelial differentiation that occurs
during nephron development [9]. These dedifferentiated
cells express genes such as vimentin and neural cell adhe-
sion molecule (NCAM), and down-regulate the transcrip-
tion factor kid-1, as seen in metanephric mesenchyme but
not mature tubule cells. These cells with mesenchymal
characteristics are able to both spread along and migrate
to denuded basement membrane [10]. Similar processes
have been reported in models of injury to the gut mucosal
epithelia [11]. Following ischemic injury to the tubule sur-
viving epithelial cells exhibit evidence of a high rate of
proliferation which occurs rapidly within 24 to 48 hours
after ischemia and is widespread in the proximal tubules
of outer medulla where injury is maximal (Fig. 1). We
have encompassed these findings in a model of tubule in-
jury and repair, whereby injured epithelial cells dediffer-
entiate and migrate to cover areas of denuded basement
membrane. They proliferate vigorously and subsequently
redifferentiate into mature polarized epithelial cells [9,
10].
In the mouse, we have developed a reproducible model
of ischemic injury in which reversible acute renal failure
is induced. Serum creatinine concentration peaks at 24
to 48 hours and the kidney shows functional recovery
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Fig. 1. Proximal tubule cell proliferation is widespread in the outer medulla following ischemic kidney injury. (A) Tubulin immunolabeling of
sections from rat kidney (×400) 2 days following ischemic injury showing mitotic spindles of injured proximal tubules cells (thick arrows). Note also
four consecutive cells, sectioned above or below the chromosomes, but showing spindle tips or ground glass cytoplasm (fine arrows), all indicative
of mitosis. (B) Periodic acid-Schiff (PAS)–stained section of mouse kidney (×400) 2 days following ischemic injury showing injured proximal
tubule cells in different stages of mitosis (thick arrows). Note also (insert) a dedifferentiated cell in telophase lining an injured tubule filled with
PAS-positive debris.
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Fig. 2. In enhanced green fluorescence protein (eGFP) bone marrow chimeras, ischemic kidney injury recruits bone marrow–derived cells to the
interstitium, not the renal tubule. (A) Section of contalateral kidney (×200) from eGFP chimeric mouse showing small numbers of eGFP-positive
cells in the interstitium, but no eGFP cells in the tubules. Note tubules are weakly visible due to autofluorescence. (B) Section of outer medulla
(bottom left) and cortex of kidney (×200) 7 days postischemia showing increased eGFP-positive cells in between the tubules, but no evidence of
eGFP-positive cells in the tubules. (C) Section of spleen from eGFP chimera (×200) showing red pulp surrounding white pulp (bottom right). Note
many cells expressing eGFP in both areas of the spleen. (D) Section of kidney (×400) from eGFP bone marrow donor mouse. Tubules and cells
between the tubules express eGFP. (E) Flow cytometric histograms of purified peripheral blood leukocytes showing background levels of green
fluorescence in leukocytes of control recipient mouse (lefthand panel) and a very high percentage of eGFP and leukocytes in eGFP chimeric mouse
(righthand panel).
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by 14 days. We have previously assessed proliferation by
proliferating cell nuclear marker (PCNA) staining and 5-
bromo-2′-deoxyuridine (BrdU) incorporation in the ro-
dent, indicating that there is widespread proliferation of
cells of the proximal tubule at 24 hours, peaking at 48
hours in the rat [9, 12]. Mitotic cells are abundant as
shown in Figure 1A, in which antitubulin antibodies have
been used to stain the mitotic spindle in the rat. Similarly
in the mouse mitotic cells, identified by periodic acid-
Schiff (PAS) (Fig. 1B) staining, confirm that proximal
tubule proliferation is both rapid and widespread follow-
ing ischemic injury in the kidney. Indeed, at 48 hours 4.5
± 0.4% of all proximal tubule cells in the outer medulla
are in mitosis and 63.7 ± 4.7% of the same population of
cells express PCNA in the mouse [13].
BMSCs DO NOT BECOME TUBULE CELLS
DURING REPAIR FOLLOWING INJURY
The model of tubule regeneration from dedifferenti-
ated, proliferating surviving epithelial cells [14] has been
called into question by reports indicating that BMSCs
contribute to new epithelial cells in the regenerating
kidney [5–8]. We generated three models of bone mar-
row chimerism in mice in order to study the possibil-
ity that BMSCs play a role in tubule regeneration [13].
Six weeks after transplantation of marrow expressing en-
hanced green fluorescent protein (eGFP) into lethally
irradiated mice, chimerism was confirmed by examina-
tion of spleen and leukocyte. Subsequently, mice un-
derwent unilateral ischemic injury, and kidneys were
assessed at 2 days and 7 days for replacement of epithe-
lial cells by cells of bone marrow origin. Multiple sec-
tions through cortex, outer medulla, and inner medulla
through each postischemic kidney were examined by flu-
orescence microscopy. Compared with contralateral and
sham-operated kidneys there was a marked increased in
eGFP-expressing cells in the interstitium (Fig. 2A and
B) consistent with the important role of inflammation in
the pathophysiology of acute kidney injury [15]. By con-
trast, we could not identify tubule cells expressing eGFP
in either postischemic kidneys or contralateral kidneys
(Fig. 2B). Kidneys from the bone marrow donor mice
expressed eGFP strongly in both epithelial and nonep-
ithelial cells (Fig. 2D). Examination of spleen of recipi-
ents revealed eGFP-positive cells in both white pulp and
red pulp zones confirming chimerism (Fig. 2C). Periph-
eral blood leukocytes were assessed by flow cytometry
for eGFP fluorescence. 73.5 ± 3.5% of circulating leuko-
cytes expressed detectable eGFP by this method (Fig. 2E)
[13]. Blood leukocytes from donor mice exhibited a simi-
lar proportion of eGFP positive leukocytes (77.7 ± 3.3%)
(Fig. 2E). Thus, if cells of bone marrow origin had dif-
ferentiated into tubule cells we would have expected to
see eGFP positive tubular cells. Most of the interstitial
Fig. 3. In gender-mismatched chimeras, ischemic kidney injury recruits
bone marrow–derived cells to the interstitium, not the renal tubule. (A)
Section showing the outer medulla of kidney 15 days postischemia.
Section has been hybridized with fluorescent probe (green) to detect Y
chromosome, counterstained with lotus lectin (red) to highlight proxi-
mal tubule cells and counterstained with DAPI (blue) to show nuclei.
Note intratubular casts in some tubules. Note also that many cells be-
tween tubules have the Y chromosome within their nuclei (arrows), but
none of the tubule cells have the Y chromosome. (B) Section of spleen
(X320) from the chimeric mouse showing many cells with the Y chro-
mosome, confirming chimerism. (C) Two tubule cells (×600) appear to
have positive hybridization in their nuclei as viewed by standard epiflu-
orescence microscopy suggesting they are derived from bone marrow
cells. (D) Deconvolution of the same area of section viewed in (C) re-
veals that the green probe aggregates are clearly lying adjacent to the
tubule nuclei not within the nuclei, indicating that these “positive” cells
are artifacts.
cells expressing eGFP in the postischemic tissues also
stained with anti-CD11b antibodies, which label cells of
the myeloid lineage, and/or anti-CD45 (leukocyte com-
mon antigen) [13]. Nevertheless, 0.5 ± 0.6% of eGFP-
positive interstitial cells did not express the leukocyte
common antigen, indicating that they were not leukocytes
(see below). To determine whether other forms of injury
to the kidney might induce bone marrow stem cells to be-
come tubule cells we induced unilateral ureteric obstruc-
tion in well-characterized eGFP chimeric mice. Although
this is a model of disease progression involving interstitial
fibrosis, tubule injury is widespread and results in marked
proliferation of tubular epithelial cells. Seven days fol-
lowing injury, kidneys were examined by fluorescence
microscopy. Multiple sections from each kidney through
cortex, outer medulla, and inner medulla were examined.
There was no evidence for bone marrow–derived tubule
epithelial cells (not shown).
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Since we had found no evidence for tubule cell replen-
ishment by BMSCs using eGFP chimeras, we looked at
another model to ask the same question. Chimeric mice
were generated in which female mice were lethally irra-
diated and rescued by bone marrow transplantation us-
ing male whole bone marrow [13]. Both unilateral and
bilateral ischemic injury was induced and kidneys were
assessed 7 days and 15 days postischemia. Cells derived
from bone marrow will have the Y chromosome, which
can be detected by in situ hybridization using a fluo-
rescent probe (FISH). Postischemic kidneys were ex-
amined with a probe for the Y chromosome adopting
established methods [5]. To confirm chimerism, spleens
and other organs were examined for cells prossessing the
chromosome. Widespread hematopoietic chimerism was
confirmed in each case (Fig. 3B). Kidneys were counter-
stained with antibodies against lotus lectin to highlight the
proximal tubule. As expected, there was an increase in the
number of interstitial cells bearing the Y chromosome in
the nucleus (Fig. 3A). Careful assessment of the postis-
chemic kidneys appeared to show a low percentage (0.06
± 0.01%) of Y chromosome–positive tubule cells when
assessed by conventional fluorescence microscopy (not
shown). When nulliparous female mouse postischemic
kidneys were assessed in identical conditions, however,
a similar low level of apparently chromosome-positive
tubule cells was present (Fig. 3C). Uninjured chimeric
kidneys also showed a similar low level of positive epithe-
lial cells. When these apparently positive cells were as-
sessed in more detail by three-dimensional deconvolution
microscopy, it became clear that all cases of apparently Y
chromosome–positive tubule cells were artifacts caused
either by nonspecific binding of probe aggregates to the
section overlying or adjacent to the nucleus (Fig. 3D), or
due to binding of the probe to the nucleus of an overlying
leukocyte.
Several studies have utilized the LacZ reporter sys-
tem to trace lineage of cells in the kidney. We generated
chimeric mice using this reporter system as a third model.
After 6 weeks of chimerism, tail bleeds confirmed bac-
terial b-galactosidase (b-gal) bearing circulating leuko-
cytes. Unilateral ischemic injury was performed and mice
were assessed 2 days, 7 days, and 15 days after injury [13].
Kidney tissue sections were assessed for bacterial b-gal
bearing cells by two methods. First, fluorescently labeled
specific antibodies were used to identify bacterial b-gal in
the tissues. As a positive control, sections of spleen were
labeled simultaneously. We examined multiple sections of
postischemic and contralateral kidneys with this method
and found no evidence for epithelial cell labeling with
antibacterial b-gal antibodies [13]. To detect low-level
expression of b-gal in these mice, bacterial b-gal activ-
ity was also assessed in tissues using 5-bomo-4-chloro-3-
indolyl-b-D-galactopyranoside (X-gal) staining solution
at pH 7.5. At this pH the endogenous mammalian b-gal,
which is strongly expressed in proximal tubules, particu-
larly in the S3 segment of the proximal tubule found in the
outer medulla, is suppressed, enabling more specific de-
tection of bacterial b-gal activity marking donor animal
cells [13]. Tissue sections were incubated overnight and
examined. While there were interstitial cells staining blue
with the X-gal solution, we found only one tubule pos-
itive cell after examination of many tissue sections [13].
Given the possibility that this single positive cell reflected
endogenous b-gal activity our conclusion is that, follow-
ing ischemic injury in this model of chimerism, there was
no conclusive evidence for any tubule cell replacement
by bone marrow cells. Thus, three different models of
chimerism failed to show evidence that any significant
number of tubule cells are derived from bone marrow
cells after 8 weeks of chimerism in healthy kidneys, nor
following injury where there is regeneration of tubules
with the appearance of new cells. The current data do not
exclude a role for resident kidney stem cells. However,
our laboratory’s prior data that essentially all surviving
epithelial cells in the outer medulla after an ischemic in-
sult are dedifferentiated, as evidenced by their expres-
sion of the mesenchymal marker, vimentin [9], suggests
that mature differentiated epithelial cells that survive the
insult have the capacity to dedifferentiate, divide, and re-
pair the epithelium. Recently, the contribution of BMSCs
to regeneration of the myocardium of the heart, islet cells
of the pancreas and hepatocytes has also been called into
question [16–18].
BONE MARROW CELLS MAY DIFFERENTIATE
INTO PERITUBULAR ENDOTHELIAL CELLS
In order to determine the identity of nonepithelial cells
of the kidney derived from bone marrow, we used the
eGFP chimera model primarily to colabel tissue sections
with leukocyte markers and found that 0.5 ± 0.6% of
eGFP expressing cells in sections of postischemic kid-
neys lacked the leukocyte common antigen, indicating
that they were not leukocytes. Between the tubules lie
interstitial fibroblasts and peritubular capillaries. Tissue
sections were therefore colabeled with antibodies against
a-smooth muscle actin (a-SMA) to detect fibroblasts and
against both von Willebrand factor and CD31 to detect
endothelial cells. Because cells in the interstitium of the
kidney are tightly intertwined and because eGFP is ex-
pressed most strongly in the nucleus and less strongly in
the cytoplasm whereas a-SMA and CD31 are predomi-
nantly membrane associated and von Willebrand factor is
predominantly cytosolic, we used confocal microscopy to
evaluate whether eGFP-expressing cells might be either
fibroblasts or endothelial cells. Although the ischemia/
reperfusion model is associated with functional recovery
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there is an expansion of interstitial fibroblasts and the
laying down of interstitial matrix [19]. Careful confo-
cal study revealed that while no fibroblasts coexpressed
eGFP, small numbers of CD31+ endothelial cells and von
Willebrand factor–positive endothelial cells expressed
eGFP. These colabeled cells were part of the capillary net-
work, but appeared as either single endothelial cells or
two endothelial cells rather than whole sections of capil-
lary derived from bone marrow cells. Evidence of eGFP-
expressing endothelial cells was only found in areas of
regeneration. In areas of active inflammation we did not
find evidence of eGFP-expressing endothelial cells. The
number of bone marrow–derived peritubular capillary
endothelial cells within the outer medullary region in 7
days postischemic kidneys was scored and amounted to
only 1.6% ± 0.4 of endothelial cells [13].
INJECTION OF STEM CELLS INTRAVENOUSLY
CAN ATTENUATE RENAL INJURY WITHOUT
DIFFERENTIATING INTO KIDNEY CELLS
To understand whether stem cells could be encouraged
to differentiate into kidney cells by intravenous admin-
istration we isolated and cultured bone marrow MSCs
from the eGFP mouse. In culture these cells differen-
tiate into adipocytes, chondrocytes, and osteocytes [13].
We cultured the cells on matrigel and found they formed
capillary-like structures and expressed the endothelial
marker CD31. MSCs were then collected from matrigel
and 0.5 × 106 cells injected intravenously 2 hours after
removal of clamps and at other time points following bi-
lateral ischemic injury to the kidneys [13]. Repeated in-
jections were administered every 3 days for 2 weeks. We
did not find evidence of any MSCs in the kidneys. Never-
theless, stem cell injections attenuated disease as assessed
by peak creatinine. This is similar to the findings of Morigi
et al [8] who reported attenuation of disease by MSC in-
jections in a toxic model of kidney disease and reported
concurrent MSC differentiation into kidney tubule ep-
ithelial cells. In mice injected with aliquots of phosphate-
buffered saline (PBS), peak creatinine (mg/dL) was 1.7 ±
0.4, whereas mice injected with aliquots of stem cells had
peak creatinine of 1.0 ± 0.2. Interestingly injection of em-
bryonic fibroblasts cultured in identical conditions con-
ferred similar protection from injury without appearing in
the kidney itself. Furthermore, when MSCs were cultured
on plastic they did not confer renal protection when ad-
ministered intravenously after ischemic renal injury [13].
Thus, it appears that stem cell injections (and injections of
other cell types) can have functionally significant effects
without differentiating into renal structures. We speculate
that this effect may be immunomodulatory since injected
MSCs rapidly disappear from the circulation and may
be ingested by immune cells in the spleen liver and lungs.
These findings have been independently corroborated by
others [20].
CONCLUSION
We have studied the role of bone marrow–derived
cells in repair of the kidney following ischemic injury.
Three different detection models have been employed
for tracing the lineage of bone marrow–derived cells in
the kidney. In each case chimerism was established in
the recipient mice. In this model of renal tissue repair,
tubule cell proliferation is both widespread and markedly
enhanced following injury. In each mouse model of
chimerism we could not find evidence that cells of bone
marrow origin contribute in a significant way to the re-
plenishment of epithelial cells in the kidney either by dif-
ferentiation or fusion. As we have previously reported,
postischemic kidney tissues have increased leukocytes
derived from circulating bone marrow cells [10]. A small
number of cells of bone marrow origin lack leukocyte
markers and express endothelial cell in areas of tis-
sue marker regeneration. Injection of stem cells intra-
venously can have functional consequences on the degree
of renal injury. These cells may aid repair by modulation
of the innate inflammatory response since we found no
evidence that they differentiate into renal cells. In our
opinion tubule regeneration occurs by survival of dedif-
ferentiated epithelial cells which proliferate and rediffer-
entiate into mature functional epithelial cells.
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